Primary nasal tuberculosis during anti-tumour necrosis factor alpha treatment of a patient with rheumatoid arthritis. (December 2013)

• Record Type: Journal Article
• Authors: Ribeiro, Sofia; Ferreira, Betânia; Duarte, Raquel; Almeida, Isabel; Vasconcelos, Carlos
• Is Part Of: Scandinavian journal of infectious diseases. Volume 45:Number 12(2013:Dec.)
• Page Start: 957
• Page End: 960
• Publication Date: 2013-12
• Subjects: Communicable diseases -- Periodicals; Infection -- Periodicals; 616.9
• DOI: 10.3109/00365548.2013.818246
• Languages: English
• ISSNs: 0036-5548

Abstract

<abstract> <title>Abstract</title> <p>Anti-tumour necrosis factor alpha (anti-TNFα) therapy is increasingly used in several inflammatory disease processes, including rheumatoid arthritis. However it has a significant potential for adverse events, such as reactivation of latent tuberculosis, which is frequently found in disseminated or extrapulmonary forms. We present a rare case of primary nasal tuberculosis within the context of anti-TNFα therapy for rheumatoid arthritis. To our knowledge, this is the first reported case of primary nasal tuberculosis in a patient with rheumatoid arthritis receiving anti-TNFα therapy.</p> </abstract>